Trends in hepatitis C virus-associated mortality rates in Japan, 1998-2017

被引:4
|
作者
Hagiya, Hideharu [1 ]
Koyama, Toshihiro [6 ]
Deguchi, Matsuo
Minato, Yusuke [5 ]
Miura, Satomi [6 ]
Funahashi, Tomoko
Teratani, Yusuke
Zamami, Yoshito
Shinomiya, Kazuaki [7 ]
Kitamura, Yoshihisa [3 ]
Sendo, Toshiaki [4 ]
Hinotsu, Shiro [8 ]
Kano, Mitsunobu [2 ]
机构
[1] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Pharmaceut Biomed,Grad Sch Med Dent & Pharmaceut, Okayama, Japan
[2] Okayama Univ, Pharmaceut Biomed, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Okayama, Japan
[3] Shujitsu Univ, Sch Pharm, Dept Pharmacotherapy, Okayama, Japan
[4] Okayama Univ Hosp, Dept Pharm, Okayama, Japan
[5] Fujita Hlth Univ, Dept Microbiol, Sch Med, Toyoake, Aichi, Japan
[6] Tokushima Univ, Inst Biomed Sci, Dept Clin Pharmacol & Therapeut, Grad Sch, Tokushima, Japan
[7] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Clin Pharm, Tokushima, Japan
[8] Sapporo Med Univ, Dept Biostat & Data Management, Sapporo, Hokkaido, Japan
基金
日本学术振兴会;
关键词
death certificate; hepatitis C; mortality; vital statistics; VIRAL-HEPATITIS; NATIONAL-SURVEY; UNITED-STATES; B-VIRUS; COMBINATION; THERAPY; BURDEN; PEGINTERFERON; INFORMATION; SIMEPREVIR;
D O I
10.1111/jgh.15517
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim The current prevalence of hepatitis C virus infection and hepatitis C virus-associated mortality in Japan falls short of the World Health Organization goal of viral hepatitis elimination by 2030. We aimed to evaluate the trends in hepatitis C virus-associated mortality in Japan. Methods This nationwide observational study used the Japanese Vital Statistics from 1998 to 2017 and included all Japanese hepatitis C virus-associated deaths (84 936) of adults aged >= 40 years. We calculated the crude and age-standardized mortality rates per 100 000 persons by age and sex. Joinpoint regression analysis was used to identify significant changing points in trends and to estimate the annual percentage changes and the average annual percentage changes for the entire study period. Results The crude mortality rate per 100 000 persons (annual death number) increased from 5.5 (3548) in 1998 to 7.0 (4843) in 2005 and decreased to 4.0 (3095) in 2017. By 2017, the crude mortality rates per 100 000 persons among men and women had dropped to 3.6 and 4.3, respectively. The age-standardized mortality rate was higher in women than in men. The average annual percentage change was -3.8% (95% confidence interval: -5.0 to -2.5). The declining trend was more rapid in men (-4.5%, 95% confidence interval: -5.3 to -3.6) than in women (-2.7%, 95% confidence interval: -3.8 to -1.6). Conclusions Trends in hepatitis C virus-associated mortality rates have declined in an accelerating manner in Japan, especially among men.
引用
收藏
页码:2486 / 2492
页数:7
相关论文
共 50 条
  • [1] Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging: Long term trends in Japan
    Taura, N
    Yatsuhashi, H
    Hamasaki, K
    Nakao, K
    Daikoku, M
    Ueki, T
    Yano, K
    Matsumoto, T
    Ishibashi, H
    Eguchi, K
    HEPATOLOGY RESEARCH, 2006, 34 (02) : 130 - 134
  • [2] Incidence, mortality and survival trends of penile cancer in Lithuania 1998-2017
    Drevinskaite, Mingaile
    Patasius, Ausvydas
    Kincius, Marius
    Jonusas, Justinas
    Ladukas, Adomas
    Jievaltas, Mindaugas
    Kairevice, Laura
    Smailyte, Giedre
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: Long-term trends in Japan
    Taura, Naota
    Hamasaki, Keisuke
    Nakao, Kazuhiko
    Ichikawa, Tatsuki
    Nishimura, Daisuke
    Goto, Takashi
    Fukuta, Mariko
    Kawashimo, Hiroshi
    Miyaaki, Hisamitsu
    Fujimoto, Masumi
    Kusumoto, Kouichiro
    Motoyoshi, Yasuhide
    Shibata, Hidetaka
    Inokuchi, Kaoru
    Eguchi, Katsumi
    ONCOLOGY REPORTS, 2006, 16 (04) : 837 - 843
  • [4] Silent hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma in Japan.
    Momosaki, S
    Hsia, C
    Nakashima, Y
    Kojiro, M
    Tabor, E
    HEPATOLOGY, 1999, 30 (04) : 637A - 637A
  • [5] Hepatitis C virus-associated keratitis
    A K Jain
    J Sukhija
    J S Saini
    Y Chawla
    R K Dhiman
    Eye, 2004, 18 : 131 - 134
  • [6] Hepatitis C Virus-Associated Cancer
    Lin, Ming V.
    King, Lindsay Y.
    Chung, Raymond T.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10, 2015, 10 : 345 - 370
  • [7] Hepatitis C virus-associated keratitis
    Jain, AK
    Sukhija, J
    Saini, JS
    Chawla, Y
    Dhiman, RK
    EYE, 2004, 18 (02) : 131 - 134
  • [8] Hepatitis C Virus-Associated Cancers
    Yi, Zhigang
    Yuan, Zhenghong
    INFECTIOUS AGENTS ASSOCIATED CANCERS: EPIDEMIOLOGY AND MOLECULAR BIOLOGY, 2017, 1018 : 129 - 146
  • [9] Hepatitis C Virus-Associated Glomerulonephritis
    Tang, Sydney C. W.
    Lai, Kar Neng
    NEW INSIGHTS INTO GLOMERULONEPHRITIS: PATHOGENESIS AND TREATMENT, 2013, 181 : 194 - 206
  • [10] Hepatitis C virus-associated glomerulonephritis without hepatitis C virus in the blood
    Yamabe, H
    Nakamura, N
    Nakamura, M
    Shimada, M
    Kumasaka, R
    Fujita, T
    Osawa, H
    Okumura, K
    Oyama, N
    Momose, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) : E65 - E69